A phase 2b multi-center, randomized, partial-blind parallel cohort study to assess the efficacy and safety of treatment with GSK3228836 in participants with chronic HBV

Chronic hepatitis B virus (HBV) infection is a significant worldwide medical problem. GSK3228836 demonstrated target engagement…

Ancillary study evaluating Ch Ad 155-hli-HBV shedding in a subset of chronic hepatitis B patients enrolled in the TH HBV VV-001 study

Safety, efficacy, immunogenicity study of GSK Biologicals’ HBV viral vector and adjuvanted proteins vaccine (GSK3528869A) in adult patients with chronic Hepatitis B infection

A First-Time-In-Human study on GSK’s therapeutic vaccines to evaluate the reactogenicity, safety, immunogenicity and efficacy on…

A phase 2, randomized, adaptive, open-label platform trial to evaluate efficacy and safety of multiple combination therapies in participants with chronic hepatitis B

This is a study designed to evaluate the safety, tolerability and efficacy of New Molecular Entity…

A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naïve, HIV-1 and Hepatitis B Co-Infected Adults

Bictegravir (GS-9883) is a potent inhibitor of HIV-1 integrase that is being evaluated for the treatment…

An Open-Label, Phase 2 Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination with Efavirenz-Based Antiretroviral Therapy or Rifampicin-Containing Anti-Tuberculosis Therapy

Detection of patterns of specific immune response against tuberculosis in people with TB before and after receiving anti-TB drugs

Implementation of latent tuberculosis infection screening and novel treatment one-month Rifapentine plus Isoniazid in end-stage renal disease patients and on renal replacement therapy

This is a collaborate study done with the Renal Division, Department of Medicine, Faculty of Medicine,…

Drug-Drug Interactions Between Rifapentine and Dolutegravir in HIV/LTBI Co-Infected Individuals

This study will evaluate the potential drug-drug interactions between dolutegravir (DTG) and steady state rifapentine (RPT)…

Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients (PHOENIx MDR-TB)

A Phase 3, open-label, multicenter trial with a cluster-randomized superiority design (eligible contacts in the same…

Host gene-expression in blood for the diagnosis and monitoring of active tuberculosis among HIV infected individuals: Prospective cohort study

Prospective Multicentre Evaluation of the Accuracy and Diagnostic Yield of the Fujifilm SILVAMP TB LAM (FujiLAM) Test for the Diagnosis of Tuberculosis in People Living With HIV

This is a prospective, multi centre cohort study in which the accuracy and the diagnostic yield…

Pilot Study for Development of Microneedles for Diagnosis of Latent Tuberculosis Infection

The cross-sectional study to investigate the effect of microneedle formulations and lengths of Tuberculin PPD microneedles…

Performance evaluation of Fujifilm SILVAMP TB LAM compared to Alere Determine™ TB LAM Antigen (Ag) for the detection of tuberculosis in children, adolescent and adult living with and without HIV in Thailand

A novel urine-based assay was co-developed by FIND and Fujifilm; the Fujifilm SILVAMP TB LAM (Fuji…

Efficacy, safety and pharmacokinetics of Dolutegravir 50 mg once daily with food versus Dolutegravir 50 mg twice daily in HIV/TB co-infected patients receiving rifampin-based anti-tuberculosis therapy

This is a stage II, randomized, open-label study describing the efficacy and safety of DTG 50…